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ABSTRACT
Objectives: Adverse drug reaction (ADR) is an important cause of morbidity, mortality, and prolonged hospitalization. The objective of this study is to 
measure the incidence, types, and nature of ADR in a tertiary care hospital located in Silchar, Assam.
Methods: A retrospective noninterventional analysis of all ADRs reported by ADR Monitoring Centre, Department of Pharmacology, Silchar Medical 
College, from March 2014 to February 2015 was performed. A total of 162 predesigned forms were used for collection of data. All forms were duly 
checked for completeness, if not, they were rejected.
Results: A total of 162 forms were assessed of which 96 (59%) were females and 66 (41%) were males. The distribution of ADRs in different age groups 
were found to be 3 (1.85%) in 0-15 years, 71 (43.82%) in 16-30 years, 65 (40.12%) in 31-45 years, 8 (4.93%) in 46-60 years, and 15 (9.25%) in age 
group >60 years. 150 (92.6%) of the ADRs were serious and 12 (7.4%) were not serious. As per the World Health Organization causality assessment 
scale, 120 (74.07%) were probable and 42 (25.92%) were possible. The most common ADR was anaphylactic reaction (AR) in 69 (42.59%) patients. 
The drugs which commonly caused ADR were iron sucrose infusions, nevirapine, cephalosporins, antiprotozoals, nonsteroidal anti-inflammatory 
drugs, and quinolones followed by others.
Conclusion: The majority of ADRs were probable. The most common ADR was AR caused by iron sucrose infusion. Different drugs caused different 
ADRs. ADRs thereby increase morbidity and mortality in patients as well as socioeconomic burden.
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INTRODUCTION
The World Health Organization (WHO) defines an adverse drug 
reaction (ADR) as - a reaction to a drug which is harmful and 
unintentional and which occurs at doses usually used in man for the 
prophylaxis, identification or treatment of disease or for the alteration 
of physiological function [1]. It is well-known that an ADR is one of the 
major causes of hospitalization, and each drug has probable adverse 
effects as well as interaction with other substances [2]. The risk of 
ADRs is governed by several factors such as dose and frequency 
of administration, genetic, and pharmacokinetic characteristics of 
special populations such as children and elderly patients and those 
with liver or kidney diseases [3]. ADRs are classified into six types: 
Dose-related (augmented), nondose-related (bizarre), dose-related 
and time-related (chronic), time-related (delayed), withdrawal (end 
of use), and failure of therapy (failure) [4]. In the recent years, there 
has been a considerable rise in the reporting of undesirable events. 
However, a concern regarding the causal relationship between the 
drug and adverse event remains and is of paramount importance in the 
present state of emerging adverse events [5]. The causality assessment 
system proposed by the WHO Collaborating Center for International 
Drug Monitoring, the WHO-Uppsala Monitoring Centre (UMC), and 
the Naranjo probability Scale are the commonly established and 
extensively used means for causality assessment as they are simple 
and easily understandable [6]. ADRs add to undue health-care costs 
by increasing morbidity and duration of hospitalization in patients. It 
also leads to mortality at times. Hence, there is an imperative need to 
generate understanding among physicians and the population toward 
ADR monitoring [7]. Owing to the need of the situation, we conducted a 
retrospective study to measure the incidence, types, and nature of ADR 
in a tertiary care hospital located in Silchar, Assam.
METHODS
A total of 162 predesigned forms were used for collection of data 
during the period from March 2014 to February 2015. The study was 
conducted in the Department of Pharmacology, Silchar Medical College 
and Hospital, Silchar, Assam. Only the forms that were filled up were 
included in our study. The study was duly approved by the Institutional 
Ethics Committee. Causality assessment was done using the WHO-UMC 
causality assessment scale. Statistical analysis was performed using 
Chi-square test; p<0.05 was considered to be significant.
RESULTS
A total of 162 forms were collected and analyzed. Out of 162, 96 (59%) 
were females and 66 (41%) were males (Fig. 1). The distribution of 
ADRs in different age groups was found to be 3 (1.85%) in 0-15 years, 
71 (43.82%) in 16-30 years, 65 (40.12%) in 31-45 years, 8 (4.93%) 
in 46-60 years, and 15 (9.25%) in age group >60 years (Fig. 2). Out of 
162 ADRs, 150 (92.6%) of the ADRs were serious and 12 (7.4%) were 
not serious (Fig. 3); p value was highly significant (p<0.0001). Causality 
assessment was done on the WHO-UMC causality assessment scale, 
120 (74.07%) were probable and 42 (25.92%) were possible (Fig. 4).
The most frequent ADR was anaphylactic reaction (AR) which occurred 
in 69 (42.59%) patients. A maculopapular rash was observed in 
20 (12.34%) patients, erythematous rash in 15 (9.25%) patients, 
urticarial rash in 10 (6.17%) patients, extrapyramidal symptom in 
6 (3.7%) patients, fixed drug eruption in 5 (3.08%) patients, Steven–
Johnson syndrome in 4 (2.46%) patients, toxic epidermal necrolysis in 
3 (1.85%) patients, and others such as respiratory discomfort, itching, 
fever, and vomiting in 30 (18.51%) patients (Fig. 5).
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Out of 69 ARs, 33 (47.82%) was caused by iron sucrose infusions, 
16 (23.18%) were caused by amino acid derivative infusions, 
9 (13.04%) each occurred from the use of human albumin and 
antimicrobial infusions, and 1 (1.44%) each from blood transfusion and 
dextrose-normal saline infusion (Fig. 6).
Other adverse effects are summarized as in (Table 1).
DISCUSSION
Our study was a retrospective analysis of ADR conducted in the Department 
of Pharmacology, Silchar Medical College and Hospital, Silchar, Assam. In 
our study, we found that females (59%) were more commonly affected 
by ADRs than males (41%). However, Shamna et al. (2014) and Patel and 
Marfatia (2008) in their study found that males were mostly affected. This 
difference may be because of the fact that in our institution a significant 
number of ADRs were reported from the department of obstetrics and 
gynecology as compared to other clinical departments [8,9]. The majority 
of ADRs were seen in age group of 16-30 years. Similar findings were 
revealed by Sharma et al. (2001) in their study [10].
The causality assessment was done using the WHO-UMC causality 
assessment scale. Out of 162 ADRs, 120 (74.07%) were probable and 
42 (25.92%) were possible. This was comparable to the earlier meta-
analysis by Lazarou et al. (1998) where bulk of the ADRs was of serious 
type [11].
In our study, we found that most common ADR was AR which was 
caused by iron sucrose infusion. Rampton et al. (2014) and Sav et al. 
(2007) in their respective study observed that iron sucrose infusions 
were associated with ARs [12,13].
Fig. 1: The distribution of gender
Fig. 2: The age group distribution
Fig. 3: The nature of seriousness of adverse drug reactions
Fig. 4: The causality assessment classification as per the World 
Health Organization-Uppsala Monitoring Centre causality 
assessment scale
Fig. 5: The distribution of different types of adverse drug reaction
Fig. 6: The distribution of drugs causing anaphylactic reaction
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The most common offending drugs responsible for ADRs were iron 
sucrose infusions in 20.37%. This was followed by fluoroquinolones, 
penicillins, and cephalosporins. Stavreva et al. (2008) in their revealed 
that the predominance of cephalosporins and Hussain et al. (2010) in 
their study found that fluoroquinolones were most accounted for ADR, 
whereas Priyadharsini et al. (2011) in their study found penicillin to be 
the most common drug causing ADR [14-16].
CONCLUSION
ADRs are among the foremost causes of morbidity, mortality, and 
prolonged hospitalization in patients. The results that we have 
obtained in our study offer an insight to the health-care professionals 
on the significance of scrutinizing and reporting of ADRs. It is essential 
for the health-care system to endorse the unprompted reporting of 
ADRs, suitable documentation and episodic reporting to regional or 
national pharmacovigilance centers to warrant drug safety. It is very 
important to plan the method of ADR monitoring in such a way that it 
gives confidence to clinicians, other medical and health-care personnel 
to report ADRs spontaneously and extensively.
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Table 1: The different adverse reactions and the most common 
drug causing them as per our study
Adverse reaction Most common drug
MR Antiviral (nevirapine)
ER Antibacterials (amoxicillin-clavulanic 
acid, piperacillin+tazobactam, 
levofloxacin, cefixime, ceftriaxone)
FDE Fixed-dose combination drugs 
such as (ofloxacin+ornidazole, 
ciprofloxacin+ornidazole)
UR Antibacterials (ceftazidime, 
ciprofloxacin)
SJS Nonsteroidal anti-inflammatory 
drug (paracetamol)
TEN Nonsteroidal anti-inflammatory 
drug (nimesulide)
Others such as fever, 
vomiting, and respiratory 
discomfort
Amino acid derivatives
MR: Maculopapular rash, ER: Erythematous rash, FDE: Fixed drug eruptions, 
UR: Urticarial rash, SJS: Steven–Johnson Syndrome, TEN: Toxic epidermal 
necrolysis
